Ftse Mib
33.843,38
0,23%
DAX
19.885,38
-0,16%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
0,00%
Bitcoin
96.107,79
1,05%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Stevanato Group SpA (STVN) Stevanato Group SpA (STVN) Notizie

STVN

Stevanato (STVN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:STVN
DataOraFonteTitoloSimboloCompagnia
14/11/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
14/11/202421:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:STVNStevanato Group SpA
11/11/202412:32Business WireStevanato Group to Present at Upcoming Investor ConferencesNYSE:STVNStevanato Group SpA
05/11/202412:31Business WireStevanato Group Reports Financial Results for the Third Quarter of 2024NYSE:STVNStevanato Group SpA
22/10/202422:30Business WireStevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024NYSE:STVNStevanato Group SpA
01/10/202412:30Business WireStevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI MilanNYSE:STVNStevanato Group SpA
26/09/202413:04Business WireStevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”NYSE:STVNStevanato Group SpA
04/09/202422:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:STVNStevanato Group SpA
06/08/202412:31Business WireStevanato Group Reports Financial Results for the Second Quarter of 2024NYSE:STVNStevanato Group SpA
25/07/202412:30Business WireStevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024NYSE:STVNStevanato Group SpA
31/05/202422:30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:STVNStevanato Group SpA
30/05/202411:00Business WireStevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and CartridgesNYSE:STVNStevanato Group SpA
28/05/202413:00Business WireStevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroNYSE:STVNStevanato Group SpA
24/05/202422:10Business WireStevanato Group Announces Results of Annual General MeetingNYSE:STVNStevanato Group SpA
20/05/202422:37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:STVNStevanato Group SpA
09/05/202412:39Business WireStevanato Group Reports Financial Results for the First Quarter of 2024NYSE:STVNStevanato Group SpA
01/05/202422:30Business WireStevanato Group to Present at the Bank of America Securities Healthcare ConferenceNYSE:STVNStevanato Group SpA
25/04/202422:04Business WireStevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024NYSE:STVNStevanato Group SpA
04/04/202414:00Business WireStevanato Group appoints Ugo Gay as Chief Operations OfficerNYSE:STVNStevanato Group SpA
26/03/202421:10Business WireStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesNYSE:STVNStevanato Group SpA
22/03/202404:45Business WireStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
20/03/202422:12Business WireStevanato Group Announces Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
11/03/202422:05Business WireStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNYSE:STVNStevanato Group SpA
07/03/202412:30Business WireStevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023NYSE:STVNStevanato Group SpA
22/02/202422:30Business WireStevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024NYSE:STVNStevanato Group SpA
24/01/202414:00Business WireStevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationNYSE:STVNStevanato Group SpA
03/01/202422:30Business WireStevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:STVNStevanato Group SpA
16/11/202312:00Business WireStevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingNYSE:STVNStevanato Group SpA
09/11/202312:30Business WireStevanato Group to Present at the Jefferies London Healthcare ConferenceNYSE:STVNStevanato Group SpA
31/10/202311:30Business WireStevanato Group Reports Third Quarter 2023 Financial ResultsNYSE:STVNStevanato Group SpA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:STVN

La tua Cronologia

EU
CACMR
CAC Mid 60 Gross Return
EU
BPKL
BPCE SFH SA 0.01% To18ma...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network